{"id":12305,"date":"2026-03-04T10:50:00","date_gmt":"2026-03-04T10:50:00","guid":{"rendered":"https:\/\/magazines.uthscsa.edu\/mission\/?p=12305"},"modified":"2026-03-10T18:14:20","modified_gmt":"2026-03-10T18:14:20","slug":"changing-the-type-2-trajectory","status":"publish","type":"post","link":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-type-2-trajectory\/","title":{"rendered":"Changing the Type 2 trajectory: The race to reverse childhood diabetes"},"content":{"rendered":"

Researchers are racing to turn around troubling trends in the rise of child and adolescent diabetes<\/em><\/span><\/h4>\n

 <\/p>\n

South Texas has become an epicenter for obesity and Type 2 diabetes, with about 16% of San Antonians \u2014 or one in six \u2014 living with Type 2 diabetes. And experts are seeing a disturbing trend of this disease among young people.<\/p>\n

\u201cThe rates of Type 2 diabetes over the last 20 years have dramatically risen in children,\u201d said Jane Lynch, MD, FAAP<\/a>, pediatric endocrinologist and interim chief of the Division of Endocrinology in the Joe R. and Teresa Lozano Long School of Medicine<\/a>. \u201cIn fact, of all our new onset children with diabetes, 50% are over the age of 10 and can present very sick.\u201d<\/p>\n

Five years ago, a child as young as five years old was diagnosed with Type 2 diabetes, Lynch added.<\/p>\n

The growing rate of diabetes and prediabetes is a major public health issue, said Marzieh Salehi, MD, MS, FACP<\/a>, an endocrinologist and a professor of medicine in the Long School of Medicine.<\/p>\n

\u201cIf a child went to the emergency room 20 years ago and they had high glucose numbers, most definitely the diagnosis was Type 1 diabetes, meaning that the pancreas cannot produce the insulin,\u201d Salehi said.<\/p>\n

\"\"
\u201cFor obesity, one of our biggest worries now is the high rates of hypertension, fatty liver and sleep apnea that go along with the weight gain and lead to adult complications at an earlier age.\u201d \u2014 JANE LYNCH, MD, FAAP<\/figcaption><\/figure>\n

Now, particularly in adolescents with high glucose numbers, the diagnosis is just as likely to be Type 2 diabetes, Lynch said. While the initial intervention for adolescents is always to make lifestyle changes, the use of approved medications is sometimes appropriate to lower insulin resistance and appetite, added Lynch.<\/p>\n

As experts in their fields \u2014 Lynch in pediatric endocrinology and Salehi in adult endocrinology \u2014 these two investigators are paving the way for improvements in the treatment of Type 2 diabetes through landmark research into medications that could help stem the tide of this growing epidemic.<\/p>\n

The rise in Type 2 among youth <\/strong><\/span><\/h4>\n

A number of factors have contributed to the rise in childhood Type 2 diabetes, including more sedentary lifestyles and increasing rates of obesity, said Lynch. With the hot summers, social deserts in which children may be disconnected from larger social networks and limited outdoor activities, the rate of obesity in South Texas continues to outpace the national average, she added.<\/p>\n

\u201cObesity continues to rise in children,\u201d Lynch said, adding that, nationally, from 2017 to 2020, it was estimated that 20% of adolescents in the United States were obese, with similar trends in other countries.<\/p>\n

\u201cFor obesity, one of our biggest worries now is the high rates of hypertension, fatty liver and sleep apnea that go along with the weight gain and lead to adult complications at an earlier age,\u201d Lynch said.<\/p>\n

\u201cIn the U.S., the prediction i\"\"s that about 60% of children will become obese by age 35, and if you\u2019re a teenager, you have a 90% chance of staying obese in adulthood,\u201d Lynch said.<\/p>\n

Obesity, particularly when associated with increased stomach fat distribution and increased fat in the liver and skeletal muscle, is a major risk factor for prediabetes and Type 2 diabetes.<\/p>\n

Developing Type 2 diabetes depends not only on body mass index and obesity, but also on one\u2019s predisposition to insulin resistance, and this can be impacted by one\u2019s ethnic and genetic background, Lynch said.<\/p>\n

\u201cYou might have two kids\u00a0with the same body mass index, but one who comes from a family with a high rate of Type 2 diabetes will be much more predisposed to having the disease than the other child,\u201d Lynch said.<\/p>\n

Puberty is a high-risk time <\/strong><\/span><\/h4>\n

Type 2 diabetes is rooted in two disorders: The body can\u2019t produce enough of the hormone insulin to lower blood sugar, and at the same time, the body is resistant to the action of insulin. Insulin resistance hinders the body\u2019s ability to lower blood sugar levels and can increase the risk of developing Type 2 diabetes.<\/p>\n

\u201cWe know that children who are obese by the age of 10 have become much more insulin resistant with pubertal hormones. Thus puberty, similar to pregnancy, creates a high-risk time for diabetes development in susceptible individuals,\u201d Lynch said, adding that the first sign of insulin resistance is acanthosis, or darkening and thickening of the skin around the neck.<\/p>\n

Interestingly, girls are more insulin resistant than boys, with two girls for every one boy diagnosed with Type 2 diabetes before the age of 18, Lynch said. Girls with insulin resistance are also at high risk for developing polycystic ovary syndrome \u2014 an endocrine disorder marked by a hormonal imbalance. Boys with insulin resistance are at high risk for fatty liver, Lynch added.<\/p>\n

Lifestyle changes and bariatric surgery <\/strong><\/span><\/h4>\n

Because obesity is a risk factor for developing Type 2 diabetes, the American Academy of Pediatrics recommends that children age 6 and over in the overweight or obese categories begin lifestyle treatments to limit sweet drinks and portion sizes and set activity goals. However, multiple studies have shown that lifestyle changes have been fairly ineffective, Lynch said, and many pediatricians may not have the time needed to devote to counseling.<\/p>\n

Another treatment option for children with Type 2 diabetes is bariatric surgery, which changes the internal workings of the stomach to reduce food intake. However, this highly intensive surgery in children is considered only under strict criteria, and the decision process is more complex than for adults, Salehi said.<\/p>\n

\u201cThe selection of candidates in this age group involves more stringent requirements and extensive multidisciplinary support,\u201d Salehi said. \u201cParental involvement and commitment to the child\u2019s long-term care and lifestyle changes are essential. Additionally, insurance coverage can vary and is often more limited for pediatric cases, which may further influence decision-making.\u201d<\/p>\n

As such, these surgeries remain relatively uncommon in children and are typically reserved for severe cases, Salehi said.<\/p>\n

While bariatric surgery may not be the most-utilized option for children, the effectiveness of this surgery on both children and adults has played a role in the development of medications that have become increasingly popular not only for their antidiabetic and anti-obesity applications, but for their cardiovascular, cognitive, kidney and sleep apnea benefits. And researchers like Lynch and Salehi are at the forefront of this breakthrough research.<\/p>\n

Game-changing medications <\/strong><\/span><\/h4>\n

The diabetes and weight loss medications now sweeping the nation are made to mimic the action of two naturally made gut hormones: glucagon-like peptide 1, or GLP-1, and glucose-dependent insulinotropic polypeptide, or GIP. These gut hormones are released after eating and regulate blood sugar by stimulating insulin release.<\/p>\n

Interestingly, the very first GLP-1 receptor agonist was discovered in the mid-1990s in the venom of a Gila monster, a lizard native to the southwestern United States and Mexico. According to the U.S. Department of Veterans Affairs<\/a>, researchers found that the hormone in the Gila monster venom \u2014 called exendin-4 \u2014 stimulates the body\u2019s insulin production and works like the GLP-1 hormone found in the digestive tract in humans. The discovery was licensed to a pharmaceutical company to develop into a drug, and a synthetic version of exendin-4 was approved for medical use by the U.S. Food and Drug Administration in 2005 and sold commercially.<\/p>\n

Clinical trials leading up to the drug\u2019s approval demonstrated improvements in glycemic control accompanied by weight loss and no risk of hypoglycemia, Salehi said. Since then, multiple GLP-1 and GIP-based medications have been developed not only for diabetes and obesity, but also for related complications such as cardiovascular disease, kidney disease, sleep apnea and neurodegenerative conditions like Alzheimer\u2019s disease. Ongoing trials are underway to explore the metabolic benefits of molecules that mimic the action of other hormones involved in weight loss and liver metabolism in addition to those for GLP-1 and GIP medications.<\/p>\n

\u201cThis is a new horizon for targeted treatment of various metabolic conditions and reduction of metabolic-related mortality,\u201d Salehi said. In fact, Salehi is leading the first-of-its-kind clinical trial<\/a> on the impact of a GLP-1 medication on the regulation of blood sugar in people with spinal cord injuries and Type 2 diabetes. This population has a two- to three-times higher rate of Type 2 diabetes, more metabolic conditions and much higher rates of fatty liver.<\/p>\n

\u201cThe immediate impact would be that we are confirming the safety of this drug in this population,\u201d Salehi said.<\/p>\n

From research to new treatments <\/strong><\/span><\/h4>\n

Researchers are now starting to mix GLP-1 medications with other gut hormones to enhance their effectiveness or reduce side effects for these drugs, Lynch said.<\/p>\n

\u201cThat\u2019s the future. These newer \u2018cocktails\u2019 of GLP-1 drugs mixed with other gut hormones \u2014 which also regulate insulin secretion and appetite \u2014 are also being studied for youth but not yet approved for those under 18,\u201d Lynch said. She has been at the forefront of studies on the effectiveness and safety of GLP-1 medications to treat Type 2 diabetes and obesity in kids.<\/p>\n

Lynch and collaborators initiated a study on treatment options for Type 2 diabetes in adolescents and youth, or TODAY. The university\u2019s Health Science Center was one of 13 sites for this landmark National Institutes of Health study spanning over a decade, with an initial study from 2004 to 2011<\/a> to evaluate the effects of one of three treatments: the use of the frontline Type 2 diabetes medication metformin to reduce blood sugar levels, the use of metformin plus the antidiabetic drug rosiglitazone, or metformin plus an intensive lifestyle intervention. The initial study included 699 adolescent participants ages 10 to 17 with youth-onset Type 2 diabetes.<\/p>\n

A follow-up, observational study was then conducted with 500 participants from 2011 to 2020. The multiyear study, published in the New England Journal of Medicine<\/em><\/a>, highlighted the devastating outcomes for youth with the onset of Type 2 diabetes before reaching the age of 18 and brought awareness to the uniquely high risks and rapid progression of complications seen in youth from this age group, Lynch said.<\/p>\n

\u201cWith this study, we realized the two-to-one ratio of girls to boys having Type 2 diabetes was national,\u201d Lynch said. \u201cWe realized the complication rates for young-onset Type 2 youth were very accelerated. Due to pubertal hormones and insulin resistance, the onset of hypertension, fatty liver, eye disease, kidney disease and heart disease were very accelerated,\u201d Lynch said.<\/p>\n

Furthermore, \u201cThe pregnancy outcomes for girls were especially scary, with unexpectedly high rates of miscarriages and fetal anomalies, so we are very motivated to be aggressive in managing Type 2 diabetes,\u201d Lynch added.<\/p>\n

The next frontier: Prevention <\/strong><\/span><\/h4>\n

Previously, Lynch participated in a study that led to the first FDA approval of a GLP-1 therapy for youth ages 10 to 18 and has been involved in studies of five categories of adult medications for kids, enabling the university to be on the frontlines of this research.<\/p>\n

Currently, she is participating in three studies involving GLP-1 medications in youth and continues to be on the forefront of the GLP-1 research among youth with Type 2 diabetes.<\/p>\n

Because of her participation in these landmark studies, Lynch likewise sits on multiple international committees to monitor safety in these types of trials for children. She credits these accomplishments and her participation in these groundbreaking studies to the expertise and skill of her research colleagues and the close collaboration between the pediatric endocrinologists and the adult diabetes unit at the university.<\/p>\n

With the now widespread use of GLP-1 medications, researchers continue to modify and mix GLP-1 hormones with other related gut hormones to further enhance the effectiveness of Type 2 diabetes medications, Lynch said.<\/p>\n

\u201cWhile we realize there may be challenges in helping families to afford approved GLP-1 medications for youth, the ability to treat kids who have Type 2 diabetes with these approved medications has been a huge game changer,\u201d Lynch said. \u201cWe now have begun to explore how to safely use these medications to prevent Type 2 diabetes and obesity-related complications, which has a lot of potential.\u201d<\/p>\n

 <\/p>\n

\n

The spinal cord injury correlation<\/strong><\/span><\/h2>\n

A pioneering clinical trial explores a safe and effective treatment option for a population more prone to developing Type 2 diabetes<\/em><\/p>\n

Those with traumatic spinal cord injuries \u2014 about 305,000 in the U.S., according to the National Spinal Cord Injury Statistical Center<\/a> \u2014 have a two- to three-times higher rate of developing Type 2 diabetes and tend to die from metabolic diseases. Yet patients with spinal cord injury and diabetes are often underdiagnosed and undertreated, missing out on effective therapies for glucose control and weight management, said Marzieh Salehi, MD, MS, FACP<\/a>, an endocrinologist and a professor of medicine at the Joe R. and Teresa Lozano Long School of Medicine<\/a> and Medical Director of the Bartter Clinical Research Unit at the Audie L. Murphy Memorial Veterans Hospital.<\/p>\n

Based on prior research conducted by Salehi and her team, individuals with spinal cord injuries and Type 2 diabetes are metabolically unique.<\/p>\n

\"\"
Marzieh Salehi, MD, MS, FACP<\/figcaption><\/figure>\n

\u201cThere\u2019s a breakdown in the communication between the gut, liver, pancreas and brain \u2014 a network that\u2019s essential for keeping blood sugar levels in check,\u201d Salehi explained. \u201cImagine what happens when that crosstalk is disrupted because neural signals can\u2019t travel properly due to a spinal cord injury.\u201d<\/p>\n

This disconnect may explain why people with spinal cord injuries have a higher risk of diabetes, fatty liver disease and other metabolic conditions and are more likely to die from cardiovascular disease than from the spinal cord injury itself, Salehi said.<\/p>\n

\u201cSince there haven\u2019t been any clinical trials in this population, physicians have been hesitant to prescribe newer medications that haven\u2019t yet been proven effective for treating diabetes and related metabolic complications in people with spinal cord injuries,\u201d Salehi added.<\/p>\n

She hopes to change that with a groundbreaking clinical trial testing whether a GLP-1 receptor agonist can counter the harmful effects of spinal cord injury on blood sugar control and weight gain. The study \u2014 which received $3 million in funding from the National Institutes of Health \u2014seeks not only to learn if this population will have any adverse effects from the medication, but also to shed more light on the underlying cause of diabetes and obesity in this population.<\/p>\n

The five-year study<\/a> is actively enrolling participants from San Antonio and community rehab clinics who have a spinal cord injury and Type 2 diabetes and are either managing their condition with the diabetes medication metformin or through diet alone.<\/p>\n

Participants will first undergo detailed metabolic testing before being randomly assigned to receive either the GLP-1 receptor agonist medication or a placebo for 24 weeks, Salehi said.<\/p>\n

The clinical trial model should allow researchers to better understand how blood sugar is processed in this population and how communication between organs influences blood sugar control and weight balance. Eventually, Salehi said, the study could pave the way for improved treatments and spark new drug development tailored to their unique metabolic needs.<\/p>\n

\u00a0<\/strong>\u201cOur findings could provide critical insights to develop targeted treatments for the unique metabolic challenges faced by people with spinal cord injuries \u2014 ultimately improving their health and quality of life.\u201d<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Researchers at UT Health San Antonio are racing to turn around troubling trends in the rise of Type 2 diabetes among children and adolescents in South Texas. <\/p>\n","protected":false},"author":634,"featured_media":12533,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[298],"tags":[],"ppma_author":[294],"class_list":["post-12305","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-winter-2025-2026"],"yoast_head":"\nChanging the Type 2 trajectory: The race to reverse childhood diabetes - Mission Magazine<\/title>\n<meta name=\"description\" content=\"South Texas has become an epicenter for obesity and Type 2 diabetes, with about 16% of San Antonians \u2014 or one in six \u2014 living with Type 2 diabetes. And experts are seeing a disturbing trend of this disease among young people. Researchers at UT Health San Antonio are racing to turn around troubling trends in the rise of child and adolescent diabetes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-type-2-trajectory\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Changing the Type 2 trajectory: The race to reverse childhood diabetes - Mission Magazine\" \/>\n<meta property=\"og:description\" content=\"South Texas has become an epicenter for obesity and Type 2 diabetes, with about 16% of San Antonians \u2014 or one in six \u2014 living with Type 2 diabetes. And experts are seeing a disturbing trend of this disease among young people. Researchers at UT Health San Antonio are racing to turn around troubling trends in the rise of child and adolescent diabetes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-type-2-trajectory\/\" \/>\n<meta property=\"og:site_name\" content=\"Mission Magazine\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-04T10:50:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-10T18:14:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2026\/03\/Type2_main.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1936\" \/>\n\t<meta property=\"og:image:height\" content=\"1148\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Orith Farago\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Orith Farago\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"12 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/changing-the-type-2-trajectory\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/changing-the-type-2-trajectory\\\/\"},\"author\":{\"name\":\"Orith Farago\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/#\\\/schema\\\/person\\\/bbf07f0a4e20d8b5901b04d1584bc26e\"},\"headline\":\"Changing the Type 2 trajectory: The race to reverse childhood diabetes\",\"datePublished\":\"2026-03-04T10:50:00+00:00\",\"dateModified\":\"2026-03-10T18:14:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/changing-the-type-2-trajectory\\\/\"},\"wordCount\":2480,\"publisher\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/changing-the-type-2-trajectory\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/wp-content\\\/uploads\\\/sites\\\/20\\\/2026\\\/03\\\/Type2_main.jpg\",\"articleSection\":[\"Winter 2025-2026\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/changing-the-type-2-trajectory\\\/\",\"url\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/changing-the-type-2-trajectory\\\/\",\"name\":\"Changing the Type 2 trajectory: The race to reverse childhood diabetes - Mission Magazine\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/changing-the-type-2-trajectory\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/changing-the-type-2-trajectory\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/wp-content\\\/uploads\\\/sites\\\/20\\\/2026\\\/03\\\/Type2_main.jpg\",\"datePublished\":\"2026-03-04T10:50:00+00:00\",\"dateModified\":\"2026-03-10T18:14:20+00:00\",\"description\":\"South Texas has become an epicenter for obesity and Type 2 diabetes, with about 16% of San Antonians \u2014 or one in six \u2014 living with Type 2 diabetes. And experts are seeing a disturbing trend of this disease among young people. Researchers at UT Health San Antonio are racing to turn around troubling trends in the rise of child and adolescent diabetes.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/changing-the-type-2-trajectory\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/changing-the-type-2-trajectory\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/changing-the-type-2-trajectory\\\/#primaryimage\",\"url\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/wp-content\\\/uploads\\\/sites\\\/20\\\/2026\\\/03\\\/Type2_main.jpg\",\"contentUrl\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/wp-content\\\/uploads\\\/sites\\\/20\\\/2026\\\/03\\\/Type2_main.jpg\",\"width\":1936,\"height\":1148},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/changing-the-type-2-trajectory\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Changing the Type 2 trajectory: The race to reverse childhood diabetes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/#website\",\"url\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/\",\"name\":\"Mission Magazine\",\"description\":\"The University of Texas Health Science Center at San Antonio Mission magazine\",\"publisher\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/#organization\",\"name\":\"Mission Magazine\",\"url\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/wp-content\\\/uploads\\\/sites\\\/20\\\/2024\\\/10\\\/UTHSA_logo_H_CMYK-350.jpg\",\"contentUrl\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/wp-content\\\/uploads\\\/sites\\\/20\\\/2024\\\/10\\\/UTHSA_logo_H_CMYK-350.jpg\",\"width\":350,\"height\":121,\"caption\":\"Mission Magazine\"},\"image\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/#\\\/schema\\\/person\\\/bbf07f0a4e20d8b5901b04d1584bc26e\",\"name\":\"Orith Farago\",\"url\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/author\\\/farago\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Changing the Type 2 trajectory: The race to reverse childhood diabetes - Mission Magazine","description":"South Texas has become an epicenter for obesity and Type 2 diabetes, with about 16% of San Antonians \u2014 or one in six \u2014 living with Type 2 diabetes. And experts are seeing a disturbing trend of this disease among young people. Researchers at UT Health San Antonio are racing to turn around troubling trends in the rise of child and adolescent diabetes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-type-2-trajectory\/","og_locale":"en_US","og_type":"article","og_title":"Changing the Type 2 trajectory: The race to reverse childhood diabetes - Mission Magazine","og_description":"South Texas has become an epicenter for obesity and Type 2 diabetes, with about 16% of San Antonians \u2014 or one in six \u2014 living with Type 2 diabetes. And experts are seeing a disturbing trend of this disease among young people. Researchers at UT Health San Antonio are racing to turn around troubling trends in the rise of child and adolescent diabetes.","og_url":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-type-2-trajectory\/","og_site_name":"Mission Magazine","article_published_time":"2026-03-04T10:50:00+00:00","article_modified_time":"2026-03-10T18:14:20+00:00","og_image":[{"width":1936,"height":1148,"url":"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2026\/03\/Type2_main.jpg","type":"image\/jpeg"}],"author":"Orith Farago","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Orith Farago","Est. reading time":"12 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-type-2-trajectory\/#article","isPartOf":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-type-2-trajectory\/"},"author":{"name":"Orith Farago","@id":"https:\/\/magazines.uthscsa.edu\/mission\/#\/schema\/person\/bbf07f0a4e20d8b5901b04d1584bc26e"},"headline":"Changing the Type 2 trajectory: The race to reverse childhood diabetes","datePublished":"2026-03-04T10:50:00+00:00","dateModified":"2026-03-10T18:14:20+00:00","mainEntityOfPage":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-type-2-trajectory\/"},"wordCount":2480,"publisher":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/#organization"},"image":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-type-2-trajectory\/#primaryimage"},"thumbnailUrl":"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2026\/03\/Type2_main.jpg","articleSection":["Winter 2025-2026"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-type-2-trajectory\/","url":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-type-2-trajectory\/","name":"Changing the Type 2 trajectory: The race to reverse childhood diabetes - Mission Magazine","isPartOf":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/#website"},"primaryImageOfPage":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-type-2-trajectory\/#primaryimage"},"image":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-type-2-trajectory\/#primaryimage"},"thumbnailUrl":"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2026\/03\/Type2_main.jpg","datePublished":"2026-03-04T10:50:00+00:00","dateModified":"2026-03-10T18:14:20+00:00","description":"South Texas has become an epicenter for obesity and Type 2 diabetes, with about 16% of San Antonians \u2014 or one in six \u2014 living with Type 2 diabetes. And experts are seeing a disturbing trend of this disease among young people. Researchers at UT Health San Antonio are racing to turn around troubling trends in the rise of child and adolescent diabetes.","breadcrumb":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-type-2-trajectory\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/magazines.uthscsa.edu\/mission\/changing-the-type-2-trajectory\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-type-2-trajectory\/#primaryimage","url":"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2026\/03\/Type2_main.jpg","contentUrl":"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2026\/03\/Type2_main.jpg","width":1936,"height":1148},{"@type":"BreadcrumbList","@id":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-type-2-trajectory\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/magazines.uthscsa.edu\/mission\/"},{"@type":"ListItem","position":2,"name":"Changing the Type 2 trajectory: The race to reverse childhood diabetes"}]},{"@type":"WebSite","@id":"https:\/\/magazines.uthscsa.edu\/mission\/#website","url":"https:\/\/magazines.uthscsa.edu\/mission\/","name":"Mission Magazine","description":"The University of Texas Health Science Center at San Antonio Mission magazine","publisher":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/magazines.uthscsa.edu\/mission\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/magazines.uthscsa.edu\/mission\/#organization","name":"Mission Magazine","url":"https:\/\/magazines.uthscsa.edu\/mission\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/magazines.uthscsa.edu\/mission\/#\/schema\/logo\/image\/","url":"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2024\/10\/UTHSA_logo_H_CMYK-350.jpg","contentUrl":"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2024\/10\/UTHSA_logo_H_CMYK-350.jpg","width":350,"height":121,"caption":"Mission Magazine"},"image":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/magazines.uthscsa.edu\/mission\/#\/schema\/person\/bbf07f0a4e20d8b5901b04d1584bc26e","name":"Orith Farago","url":"https:\/\/magazines.uthscsa.edu\/mission\/author\/farago\/"}]}},"authors":[{"term_id":294,"user_id":634,"is_guest":0,"slug":"farago","display_name":"Orith Farago","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/5e0d6ce26c9c58ffb323bb5be044885a5de990357a93e0e6bfb1423f4a2e355c?s=96&d=mm&r=g","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/posts\/12305","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/users\/634"}],"replies":[{"embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/comments?post=12305"}],"version-history":[{"count":0,"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/posts\/12305\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/media\/12533"}],"wp:attachment":[{"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/media?parent=12305"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/categories?post=12305"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/tags?post=12305"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/ppma_author?post=12305"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}